Clinical trial
Atorvastatin Treatment to Attenuate the Progression of Cardiovascular Disease in…
NCT00481364 · Ercan OK, Other · Completed
Key facts
| NCT number | NCT00481364 |
|---|---|
| Title | Atorvastatin Treatment to Attenuate the Progression of Cardiovascular Disease in Hemodialysis Patients |
| Official title | Atorvastatin Treatment to Attenuate the Progression of Cardiovascular Disease: Prospective, Randomized, Controlled Study |
| Lead sponsor | Ercan OK, Other |
| Collaborators | Pfizer Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Vascular Calcification, Atherosclerosis, Dyslipidemia, Inflammation |
| Intervention type | Drug |
| Interventions | atorvastatin, placebo |
| Enrollment | 446 |
| Start date | Nov 1, 2006 |
| Primary completion | Dec 1, 2008 |
| Completion | Dec 1, 2008 |
| First posted | Jun 1, 2007 |
| Last update posted | Sep 9, 2013 |
| Countries | Turkey (Türkiye) |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: